Biomedican
Business Services · California, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
40471 Encyclopedia Cir, Fremont, Califor...Phone Number
(405) 588-8827Website
www.biomedican.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Feb
Mar
Apr
May
Jun
Jul
ZI Rank
1
1
1
1
1
1
About Biomedican
Biomedican is a biotech startup specializing in the organic biosynthesis of rare cannabinoids and high-value compounds using patented low-cost methods and proprietary yeasts. Their product line includes pharmaceutical-grade compounds such as CBG, CBN, THCA, and THCV, produced through a sustainable fermentation process that significantly reduces costs and environmental impact. The company targets clients in the pharmaceutical and wellness industries, offering high-quality, non-GMO, and organic products that are identical to those found in nature. With a focus on high-volume production, Biomedican aims to revolutionize the cannabinoid market by providing efficient and affordable alternatives to traditional extraction methods.Explore more
Biomedican Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Biomedican your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check out if Biomedican is spiking on competitors!
Congratulate Masked Content for being promoted to Masked Content at Biomedican
Product Launch: Get notified when Biomedican launches new products
Check if Biomedican has recently received funding, and reach out quickly before it becomes old news!
Website visits: Recent activity has been detected on your website
Earning: See what the market has to say on Biomedican recently announced quarterly report
Click to see if Biomedican had a recent Job posting/layoffs
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Funding: Get notified immidiatlly once Biomedican has new funding data
Biomedican, which may be a good buyer, showed buying intent in Masked Content Topic
Recommended Actions
Reach out to Masked Content who joined Biomedican as Masked Content
Find more new buyers
Compare Similar Companies to Biomedican
Compare insights from companies similar to Biomedican, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Biomedican is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Biomedican is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Biomedican.
Biomedican Tech Stack
A closer look at the technologies used by Biomedican
See more technologies
Biomedican News & Media
Bio-Kai significantly disrupts the Astaxanthin Market with BioOrganic Compound
CEOCFO Magazine interviews Bio-Kai President Dennis O’Neill on their 100% Organic, non-GMO Astaxanthin FREMONT, CALIFORNIA, US, July 13, 2021 /EINPresswire.com/ -- CEOCFO Magazine, an independent business and investor publication that highlights …Mycotopia Therapies (20/20 Global) to Launch PsyBioMed, a Biosynthetic Compound, a Biotech Company for the Global Production of Psychedelics
Pharmaceutically pure biosynthetic compounds are expected to be promising contenders to replace synthetic and plant-extracted psychedelics. Pharmaceutically pure biosynthetic compounds are expected to be promising contenders to replace synthetic and plant-extracted psychedelics.BioMedican President Dennis O’Neill on their efforts to Leads the World in Biosynthesized Cannabinoids
CEOCFO Magazine interviews BioMedican President Dennis O’Neill on the value of providing Rare Cannabinoids FREMONT, CALIFORNIA, US, December 29, 2020 /EINPresswire.com/ -- CEOCFO Magazine, an independent business and investor publication that highlights …BioMedican President Dennis O’Neill on their efforts to Lead the World in Biosynthesized Cannabinoids
CEOCFO Magazine interviews BioMedican President Dennis O’Neill on the value of providing Rare Cannabinoids FREMONT, CALIFORNIA, US, December 29, 2020 /EINPresswire.com/ -- CEOCFO Magazine, an independent business and investor publication that highlights …
Read more news
Top Business Services Companies
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Biomedican
Sign Up For FreeTo access detailed company insights
Biomedican is a biotech startup specializing in the organic biosynthesis of rare cannabinoids and high-value compounds using patented low-cost methods and proprietary yeasts. Their product line includes pharmaceutical-grade compounds such as CBG, CBN, THCA, and THCV, produced through a sustainable fermentation process that significantly reduces cos... Read More
